0001181431-12-052108.txt : 20120926 0001181431-12-052108.hdr.sgml : 20120926 20120926160559 ACCESSION NUMBER: 0001181431-12-052108 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120924 FILED AS OF DATE: 20120926 DATE AS OF CHANGE: 20120926 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hamill John CENTRAL INDEX KEY: 0001559058 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15313 FILM NUMBER: 121111151 MAIL ADDRESS: STREET 1: 4092 NEW HOPE ROAD CITY: FURLONG STATE: PA ZIP: 18925 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 3 1 rrd356956.xml X0206 3 2012-09-24 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001559058 Hamill John 400 CROSSING BLVD 3RD FLOOR BRIDGEWATER NJ 08807 0 1 0 0 SVP, CFO Common Stock, $0.01 par value 100000 D Option to purchase Common Stock, $0.01 par value 2.92 2013-09-24 2022-09-24 Common Stock, $0.01 par value 250000 D The right to receive these shares is pursuant to a restricted stock grant that will vest as to 1/3 of the grant on each of September 24, 2013, September 24, 2014, and September 24, 2015. These stock options will vest and become exercisable as to 1/3 of the grant on each of September 24, 2013, September 24, 2014, and September 24, 2015. Irina Ishak as Attorney-In-Fact for John Hamill 2012-09-26